Horizon Will Submit Krystexxa sBLA To Strengthen Clinical Profile In Gout

 
• By Jessica Merrill
  
tree growing
Horizon sees a new opportunity to expand Krystexxa to more patients • Source: Alamy

More from Clinical Trials

More from R&D